Phenethyl trans-cinnamate

CAS No. 63238-64-2

Phenethyl trans-cinnamate( —— )

Catalog No. M28667 CAS No. 63238-64-2

Phenethyl trans-cinnamate is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 46 In Stock
10MG 65 In Stock
25MG 116 In Stock
50MG 174 In Stock
100MG 258 In Stock
200MG 392 In Stock
500MG 587 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Phenethyl trans-cinnamate
  • Note
    Research use only, not for human use.
  • Brief Description
    Phenethyl trans-cinnamate is a chemical compound.
  • Description
    Phenethyl trans-cinnamate is a chemical compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    hCNT2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    63238-64-2
  • Formula Weight
    252.31
  • Molecular Formula
    C17H16O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(/C=C/c1ccccc1)OCCc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tatani K, et al. Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors. ACS Med Chem Lett. 2015 Jan 28;6(3):244-8.
molnova catalog
related products
  • C3d Peptide P16

    C3d Peptide P16

  • Astressin

    Astressin is an amino-terminal truncated analog of CRF that retains high affinity binding to the extracellular domain of the receptor and is believed to act as a neutral competitive antagonist of receptor activation.

  • Myosin Kinase Inhibi...

    Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.